Jiangsu Gdk Biotechnology Stock Price To Earnings To Growth

688670 Stock   14.38  0.03  0.21%   
Jiangsu GDK Biotechnology fundamentals help investors to digest information that contributes to Jiangsu GDK's financial success or failures. It also enables traders to predict the movement of Jiangsu Stock. The fundamental analysis module provides a way to measure Jiangsu GDK's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jiangsu GDK stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Jiangsu GDK Biotechnology Company Price To Earnings To Growth Analysis

Jiangsu GDK's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition

Based on the latest financial disclosure, Jiangsu GDK Biotechnology has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all China stocks is 100.0% higher than that of the company.

Jiangsu Price To Earnings To Growth Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jiangsu GDK's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jiangsu GDK could also be used in its relative valuation, which is a method of valuing Jiangsu GDK by comparing valuation metrics of similar companies.
Jiangsu GDK is currently under evaluation in price to earnings to growth category among its peers.

Jiangsu Fundamentals

About Jiangsu GDK Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Jiangsu GDK Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jiangsu GDK using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jiangsu GDK Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Jiangsu Stock

Jiangsu GDK financial ratios help investors to determine whether Jiangsu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jiangsu with respect to the benefits of owning Jiangsu GDK security.